p.109 抽出テキスト

Cardiol 2012; 60: 2092-2099. PMID: 23083782 178. Abu-Zeitone A, Peterson DR, Polonsky B, et al. Efficacy of different beta-blockers in the treatment of long QT syndrome. J Am Coll Cardiol 2014; 64: 1352-1358. PMID: 25257637 179. Joglar JA, Kapa S, Saarel EV, et al. 2023 HRS expert consensus statement on the management of arrhythmias during pregnancy. Heart Rhythm 2023; 20: e175-e264. PMID: 37211147 180. Funasako M, Aiba T, Ishibashi K, et al. Pronounced Shortening of QT Interval With Mexiletine Infusion Test in Patients With Type 3 Congenital Long QT Syndrome. Circ J 2016; 80: 340-345. PMID: 26632536 181. Ruan Y, Liu N, Bloise R, et al. Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients. Circulation 2007; 116: 1137-1144. PMID: 17698727 182. Mazzanti A, Maragna R, Faragli A, et al. Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3. J Am Coll Cardiol 2016; 67: 1053-1058. PMID: 26940925 183. Crotti L, Neves R, Dagradi F, et al. Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients. Circulation 2024; 150: 531-543. PMID: 38939955 184. Aiba T, Shimizu W, Inagaki M, et al. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil. J Am Coll Cardiol 2005; 45: 300-307. PMID: 15653031 185. Compton SJ, Lux RL, Ramsey MR, et al. Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation 1996; 94: 1018-1022. PMID: 8790040 186. Etheridge SP, Compton SJ, Tristani-Firouzi M, et al. A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations. J Am Coll Cardiol 2003; 42: 1777-1782. PMID: 14642687 187. Miyamoto K, Aiba T, Kimura H, et al. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations. Heart Rhythm 2015; 12: 596-603. PMID: 25496985 188. Kannankeril PJ, Roden DM, Fish FA. Suppression of bidirectional ventricular tachycardia and unmasking of prolonged QT interval with verapamil in Andersen’s syndrome. J Cardiovasc Electrophysiol 2004; 15: 119. PMID: 15028088 189. Erdogan O, Aksoy A, Turgut N, et al. Oral verapamil effectively suppressed complex ventricular arrhythmias and unmasked U waves in a patient with Andersen-Tawil syndrome. J Electrocardiol 2008; 41: 325-328. PMID: 18353348 190. Sumitomo N, Shimizu W, Taniguchi K, et al. Calcium channel blocker and adenosine triphosphate terminate bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome. Heart Rhythm 2008; 5: 498-499. PMID: 18313615 191. Jacobs A, Knight BP, McDonald KT, et al. Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8). Heart Rhythm 2006; 3: 967-970. PMID: 16876748 192. Lambiase PD, Eckardt L, Theuns DA, et al. Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes. Heart Rhythm O

2 2020; 1: 326-335. PMID: 34113890 193. Mori H, Sumitomo N, Tsutsui K, et al. Efficacy of SubcutAneous implantable cardioVErter-defibrillators in ≤18 year-old CHILDREN: SAVE-CHILDREN registry. Int J Cardiol 2023; 371: 204-210. PMID: 36087632 194. Dorostkar PC, Eldar M, Belhassen B, et al. Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. Circulation 1999; 100: 2431-2436. PMID: 10595956 195. Keegan R, Onetto L, Gregorietti F, et al. Catheter ablation of frequent monomorphic ventricular arrhythmias in Andersen-Tawil syndrome: case report and focused literature review. J Interv Card Electrophysiol 2023; 66: 729-736. PMID: 34665385 196. Schunk PC, Ruttan T. Pediatric Syncope: High-Risk Conditions and Reasonable Approach. Emerg Med Clin North Am 2018; 36: 305-321. PMID: 29622324 197. Miyake CY, Motonaga KS, Fischer-Colbrie ME, et al. Risk of cardiac disease and observations on lack of potential predictors by clinical history among children presenting for cardiac evaluation of mid-exertional syncope. Cardiol Young 2016; 26: 894-900. PMID: 26277987 198. Tester DJ, Medeiros-Domingo A, Will ML, et al. Unexplained drownings and the cardiac channelopathies: a molecular autopsy series. Mayo Clin Proc 2011; 86: 941-947. PMID: 21964171 199. Sumitomo N, Baba R, Doi S, et al. Japanese Circulation Society and the Japanese Society of Pediatric Cardiology and Cardiac Surgery of Joint Working. Guidelines for Heart Disease Screening in Schools (JCS 2016/JSPCCS 2016) - Digest Version. Circ J 2018; 82: 2385-2444. PMID: 30101812 200. Yoshinaga M, Kucho Y, Nishibatake M, et al. Probability of diagnosing long QT syndrome in children and adolescents according to the criteria of the HRS/EHRA/APHRS expert consensus statement. Eur Heart J 2016; 37: 2490-2497. PMID: 27026747 201. Fukuyama M, Horie M, Aoki H, et al. School-based routine screenings of electrocardiograms for the diagnosis of long QT syndrome. Europace 2022; 24: 1496-1503. PMID: 35060598 202. Mitchell JL, Cuneo BF, Etheridge SP, et al. Fetal heart rate predictors of long QT syndrome. Circulation 2012; 126: 2688-2695. PMID: 23124029 203. Schwartz PJ, Moss AJ, Vincent GM, et al. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993; 88: 782-784. PMID: 8339437 204. Vink AS, Clur SB, Geskus RB, et al. Effect of Age and Sex on the QTc Interval in Children and Adolescents With Type 1 and 2 Long-QT Syndrome. Circ Arrhythm Electrophysiol 2017; 10: e004645. PMID: 28356306 205. Lawley CM, Tester M, Sanatani S, et al. Life-threatening cardiac arrhythmia and sudden death during electronic gaming: An international case series and systematic review. Heart Rhythm 2022; 19: 1826-1833. PMID: 37850595 206. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2018; 72: 1677-1749. PMID: 29097294 207. Aziz PF, Tanel RE, Zelster IJ, et al. Congenital long QT syndrome and 2:1 atrioventricular block: an optimistic outcome in the current era. Heart Rhythm 2010; 7: 781-785. PMID: 20197117 208. Shah MJ, Silka MJ, et al. Writing Committee Members. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients. Heart Rhythm 2021; 18: 1888-1924. PMID: 34363988 209. Kataoka S, Yagishita D, Yazaki K, et al. Double-device therapy in a patient with long QT syndrome. J Arrhythm 2024; 40: 639-642. PMID: 38939789 210. Olde Nordkamp LR, Postema PG, Knops RE, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm 2016; 13: 443-454. PMID: 26385533 211. Drew BJ, Ackerman MJ, Funk M, et al. American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, Council on Cardiovascular Nursing, American College of Cardiology Foundation. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 2010; 121: 1047-1060. PMID: 20142454 212. Selzer A, Wray HW. Quinidine Syncope. Paroxysmal Ventricular Fibrillation Occurring during Treatment of Chronic Atrial Arrhythmias.  Circulation 1964; 30: 17-26. PMID: 14197832 213. Schwartz PJ, Woosley RL. Predicting the Unpredictable: Drug- Induced QT Prolongation and Torsades de Pointes. J Am Coll Cardiol 2016; 67: 1639-1650. PMID: 27150690 214. Tisdale JE, Chung MK, Campbell KB, et al. American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing. Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association. Circulation 2020; 142: e214-e233. PMID: 32929996 215. Lyon AR, López-Fernández T, Couch LS, et al. ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022; 43: 4229-4361. PMID: 36017568 216. CredibleMeds ®. QTDrugs Lists. https://www.crediblemeds.org/ 217. Sarganas G, Garbe E, Klimpel A, et al. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany. Europace 2014; 16: 101-108. PMID: 23833046